The DOI matches its Crossref record.
Pet animals and foreign travel are risk factors for colonisation with extended-spectrum β-lactamase-producing Escherichia coli
Abstract
Objective The purpose of this study was to determine the prevalence of extended-spectrum β-lactamase (ESBL) and vancomycin-resistant enterococci (VRE) colonisation among healthy infection control personnel and to determine risk factors for ESBL or VRE colonisation within this group. Methods Participants were recruited at an infection control symposium in 2011. Volunteers were asked to perform a rectal swab and to fill in questionnaires on risk factors of ESBL or VRE carriage (report on diet, contact with domestic or production animals, travel, hospital stay and antibiotic use all within the last 12 months). Rectal swabs were inoculated onto ESBL and VRE chromogenic agar; species identification and susceptibility testing was done by using a VITEK 2 system. In the multivariable analysis, a logistic regression with stepwise forward variable selection was performed. Results Two hundred and thirty people participated in the study, i.e. 36 % of the symposium attendees (231/639). No VRE faecium or faecalis were isolated, whereas ESBL were isolated from 8 out of 231 individuals, i.e. 3.5 % (95 % confidence interval 1.5-6.7). In the multivariable analysis, travel to Greece or Africa and contact with pets were independently associated with ESBL positivity. The odds ratios were as follows: travel to Greece 15.2, travel to Africa 14.8 and for having a pet animal 6.7. Conclusion This is the first report showing that contact with pets increases by almost seven-fold the chance to be colonis…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Still being checked.
Research works printed but not linked: 16
- Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol. 2010;300:371–9. · DOI
- Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection. 1983;11:315–7. · DOI
- Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007;59:165–74. · DOI
- Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008;62:1142–9. · DOI
- Wieler LH, Ewers C, Guenther S, Walther B, Lübke-Becker A. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples. Int J Med Microbiol. 2011;301:635–41. · DOI
- Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect. 2008;57:441–8. · DOI
- Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54:3564–8. · DOI
- Strömdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I. Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011;30:1159–62. · DOI
- Vinué L, Sáenz Y, Martínez S, Somalo S, Moreno MA, Torres C, et al. Prevalence and diversity of extended-spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect. 2009;15:954–7. · DOI
- Sasaki Y, Tsujiyama Y, Kusukawa M, Murakami M, Katayama S, Yamada Y. Prevalence and characterization of Shiga toxin-producing Escherichia coli O157 and O26 in beef farms. Vet Microbiol. 2011;150:140–5. · DOI
- Ko YJ, Moon HW, Hur M, Park CM, Cho SE, Yun YM. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection. 2012. Epub 2012/06/23. · DOI
- Sankar S, Narayanan H, Kuppanan S, Nandagopal B. Frequency of extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacilli in a 200-bed multi-specialty hospital in Vellore district, Tamil Nadu, India. Infection. 2012. 40:425–9. · DOI
- Meyer E, Conrad A, Schneider C, Serr A, Babikir R, Dettenkofer M. Burden of imported cases of infection or colonization with multidrug-resistant organisms in a German university hospital. Infect Control Hosp Epidemiol. 2008;29:1195–6. · DOI
- Meyer E, Ziegler R, Mattner F, Schwab F, Gastmeier P, Martin M. Increase of patients co-colonised or co-infected with methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium or extended-spectrum beta-lactamase-producing Enterobacteriaceae. Infection. 2011;39:501–6. · DOI
- Baran J Jr, Ramanathan J, Riederer KM, Khatib R. Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households. Infect Control Hosp Epidemiol. 2002;23:23–6. · DOI
- van den Braak N, Kreft D, van Belkum A, Verbrugh H, Endtz H. Vancomycin-resistant enterococci in vegetarians. Lancet. 1997;350:146–7. · DOI
Cited by
Sorted by citations
Reducing the risk of pet-associated zoonotic infections
Stull, J. W., Brophy, J., & Weese, J. S. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.141020 · Cited by 177
Metadata
- Authors
- Meyer, E., Gastmeier, P., Kola, A., & Schwab, F.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Meyer, E.
- Venue
- Infection
- Published
- 2012-09-13
- Volume
- 40
- Issue
- 6
- Pages
- 685-687
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W1965561954
- Cited by
- 112
- References
- 0
- Citations by year
- 2025: 2 · 2024: 7 · 2023: 4 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 13 · 2018: 9 · 2017: 7 · 2016: 9 · 2015: 9 · 2014: 14 · 2013: 10
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Keywords
- extended-spectrum beta-lactamase, ESBL-producing Escherichia coli, vancomycin-resistant enterococci, colonization, infection control personnel, companion animals, animal contact, international travel, risk factors, antimicrobial resistance, occupational health, Greece, Africa
- MeSH terms
- Animals, beta-Lactamases, Cross Infection, Escherichia coli, Escherichia coli Infections, Humans, Surveys and Questionnaires, Risk Factors, Time Factors, Travel, Vancomycin, Prevalence, Multivariate Analysis, Vancomycin Resistance, Pets
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
